The global insulin market is projected to grow from US$ 18.5 billion in 2021 to US$ 30 billion by the end of 2031, with a CAGR of 4.3% from 2022 to 2031. The growth is driven by several factors, ...
来自MSN6 天
The Big Three Pharmacy Benefit Managers Are Countersuing the FTC. Does Their Argument Have ...The FTC filed a lawsuit in September, accusing the three major PBMs of anticompetitive rebating practices related to insulin.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈